In­smed, Al­ny­lam and oth­ers make Sci­ence's list of top 20 bio­phar­ma em­ploy­ers

East coast biotech and phar­ma com­pa­nies once again took the top four spots on Sci­ence’s list of top 20 in­dus­try em­ploy­ers this year, head­ed by In­smed for the sec­ond year in a row.

Al­ny­lam, Re­gen­eron and In­cyte fol­lowed, with the Swiss Syn­gen­ta Group rank­ing fifth, ac­cord­ing to Sci­ence. The com­pa­nies were cho­sen by more than 6,200 sur­vey re­spon­dents, more than half of whom work in R&D.

The news comes as the in­dus­try’s rep­u­ta­tion is once again on a down­ward slide. Bio­phar­ma’s sec­ond-quar­ter rep­u­ta­tion score was the low­est it’s been since the end of 2020, ac­cord­ing to cor­po­rate rep­u­ta­tion mon­i­tor Rep­Trak. The phar­ma­ceu­ti­cals, biotech and life sci­ences cat­e­go­ry fell al­most three points (2.9) be­tween the first and sec­ond quar­ter of 2022, with a one-point drop his­tor­i­cal­ly re­sult­ing in a 4% to 5% drop in sup­port.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER